The Registry of Toxic Effects of Chemical Substances
Ethylene oxide |
UPDATE: May 2005 | MW: 44.06 | MF: C2H4O |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
18 mg/6 hour
|
moderate
|
BUYRAI 31,25,1977
|
skin | human
1%/7S
|
|
AMIHBC 2,549,1950
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
parenteral | Drosophila melanogaster
55 mmol/L
|
ZEVBA5 92,457,1961
|
cytogenetic analysis
|
hamster
fibroblast
|
250 ppm
|
ESKHA5 (102),77,1984
|
cytogenetic analysis
|
inhalation | human
5 ppm/1 year
|
MUREAV 170,55,1986
|
cytogenetic analysis
|
inhalation | monkey
100 ppm/7 hour/2 year- intermittent
|
TXAPA9 76,85,1984
|
cytogenetic analysis
|
inhalation | monkey
100 ppm/104 week
|
MUREAV 492,59,2001
|
cytogenetic analysis
|
inhalation | mouse
400 ppm/6 hour- continuous
|
ARTODN 59,332,1987
|
cytogenetic analysis
|
intraperitoneal | mouse
88,120 µg/kg
|
MUREAV 288,223,1993
|
cytogenetic analysis
|
inhalation | mouse
0.5 ppb
|
EMMUEG 39,69,2002
|
cytogenetic analysis
|
rat
bone marrow
|
30 µg/L/2 day
|
TNICS* 13,47,1973
|
cytogenetic analysis
|
inhalation | rat
1 µg/L/17 week
|
TPKVAL 13,51,1973
|
cytogenetic analysis
|
oral | rat
9 mg/kg
|
TPKVAL 12,72,1971
|
dominant lethal test
|
inhalation | mouse
204 ppm/6 hour/48 day- intermittent
|
EMMUEG 16,126,1990
|
dominant lethal test
|
intraperitoneal | mouse
150 mg/kg
|
ENMUDM 2,252,1980
|
dominant lethal test
|
inhalation | rat
1,000 ppm/4 hour
|
TXAPA9 40,261,1977
|
dominant lethal test
|
subcutaneous | rat
40 mg/kg
|
GISAAA 48(1),23,1983
|
DNA adduct
|
inhalation | Drosophila melanogaster
2 ppm/24 hour
|
MUREAV 529,95,2003
|
DNA adduct
|
inhalation | mouse
100 ppm/6 hour/6 week- intermittent
|
TOXID9 72(Supp 1),249,2003
|
DNA damage
|
human
fibroblast
|
5 mmol/L
|
EMMUEG 24,161,1994
|
DNA damage
|
intraperitoneal | mouse
100 mg/kg
|
MUREAV 197,93,1988
|
DNA damage
|
inhalation | mouse
1,800 ppm/1 hour- continuous
|
MUREAV 209,177,1988
|
unscheduled DNA synthesis
|
human
leukocyte
|
4 mmol/L
|
CBINA8 47,265,1983
|
unscheduled DNA synthesis
|
inhalation | mouse
300 ppm
|
ENMUDM 1,166,1979
|
mutation in microorganisms
|
Escherichia coli
|
3,500 µmol/10 hour (-enzymatic activation step)
|
MUREAV 24,83,1974
|
mutation in microorganisms
|
Neurospora crassa
|
140 mmol/L/10 minute (-enzymatic activation step)
|
MGGEAE 101,185,1968
|
mutation in microorganisms
|
other microorganisms
|
540 mg/L (-enzymatic activation step)
|
47YKAF 8,273,1981
|
mutation in microorganisms
|
Salmonella typhimurium
|
40 µmol/plate (+enzymatic activation step)
|
FCTXAV 18,115,1980
|
mutation in microorganisms
|
Salmonella typhimurium
|
20 ppm (-enzymatic activation step)
|
EMMUEG 11,65,1988
|
mutation in microorganisms
|
Saccharomyes cerevisiae
|
25 mmol/L (-enzymatic activation step)
|
MUREAV 250,229,1991
|
micronucleus test
|
intraperitoneal | mouse
150 mg/kg
|
MUREAV 75,191,1980
|
micronucleus test
|
intravenous | mouse
200 mg/kg
|
APTOA6 43,69,1978
|
micronucleus test
|
inhalation | mouse
380 ppm/3 hour- continuous
|
ESKHA5 (102),84,1984
|
micronucleus test
|
intravenous | rat
200 mg/kg
|
APTOA6 43,69,1978
|
micronucleus test
|
inhalation | rat
200 ppm/6 hour/4 week- intermittent
|
MUREAV 324,87,1994
|
micronucleus test
|
intraperitoneal | rat
50 ppm
|
MUREAV 492,59,2001
|
gene conversion and mitotic recombination
|
Saccharomyes cerevisiae
|
25 mmol/L
|
MUREAV 250,229,1991
|
mutation in mammalian somatic cells
|
hamster
ovary
|
5 mg/L/1 hour
|
JTEHD6 12,27,1983
|
mutation in mammalian somatic cells
|
hamster
lung
|
7,500 ppm/2 hour- continuous
|
ENMUDM 8,67,1986
|
mutation in mammalian somatic cells
|
human
fibroblast
|
5 mmol/L
|
MUREAV 287,283,1993
|
mutation in mammalian somatic cells
|
intraperitoneal | mouse
200 mg/kg/3 day- intermittent
|
MUREAV 288,151,1993
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
5 µmol/L
|
PAACA3 21,74,1980
|
mutation in mammalian somatic cells
|
inhalation | mouse
200 ppm/6 hour/4 week- intermittent
|
MUREAV 392,211,1997
|
morphological transform
|
hamster
embryo
|
625 ppm/2 hour- continuous
|
ENMUDM 8,67,1986
|
morphological transform
|
mouse
embryo
|
2,500 µmol/L
|
MUTAEX 4,58,1989
|
sister chromatid exchange
|
human
lymphocyte
|
4 pph
|
TCMUD8 6,15,1986
|
sister chromatid exchange
|
human
fibroblast
|
36 ppm/24 hour
|
ZHPMAT 170,548,1980
|
sister chromatid exchange
|
human
lymphocyte
|
10 mg/L
|
PHMGBN 25,214,1982
|
sister chromatid exchange
|
inhalation | human
380 ppb/6 hour/4 year- intermittent
|
SWEHDO 17,60,1991
|
sister chromatid exchange
|
inhalation | human
60 ppm/12 week- intermittent
|
MUREAV 281,31,1992
|
sister chromatid exchange
|
inhalation | monkey
50 ppm/7 hour/2 year- intermittent
|
TXAPA9 76,85,1984
|
sister chromatid exchange
|
intraperitoneal | mouse
88,120 µg/kg
|
MUREAV 288,223,1993
|
sister chromatid exchange
|
inhalation | rat
50 ppm/6 hour/3 day- continuous
|
MUREAV 120,37,1983
|
sister chromatid exchange
|
inhalation | rat
50 ppm/4 week
|
MUREAV 492,59,2001
|
sister chromatid exchange
|
intraperitoneal | rat
50 ppm
|
MUREAV 492,59,2001
|
sister chromatid exchange
|
inhalation | rabbit
50 ppm/12 week- intermittent
|
ENMUDM 4,121,1982
|
sister chromatid exchange
|
inhalation | rabbit
250 ppm/12 week
|
MUREAV 492,59,2001
|
sister chromatid exchange
|
Saccharomyes cerevisiae
|
25 mmol/L
|
MUREAV 250,229,1991
|
sex chromosome loss and nondisjunction
|
parenteral | Drosophila melanogaster
55 mmol/L
|
ZEVBA5 92,457,1961
|
specific locus test
|
parenteral | Drosophila melanogaster
114 mmol/L
|
CNREA8 30,195,1970
|
specific locus test
|
inhalation | Drosophila melanogaster
750 ppm
|
MUREAV 405,259,1998
|
specific locus test
|
inhalation | Drosophila melanogaster
3.9 ppm/24 hour
|
MUREAV 529,95,2003
|
specific locus test
|
inhalation | mouse
0.5 ppb
|
EMMUEG 39,69,2002
|
heritable translocation test
|
intraperitoneal | mouse
30 mg/kg/25 day- intermittent
|
ENMUDM 2,252,1980
|
heritable translocation test
|
inhalation | mouse
165 ppm/6 hour/48 day- intermittent
|
EMMUEG 16,126,1990
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | monkey
lowest published toxic concentration: 50 ppm/7 hour (96 week male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
ATAREK 8-84,7,1984
|
inhalation | monkey
lowest published toxic concentration: 50 ppm/7 hour (2 year male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
TOXID9 3,60,1983
|
inhalation | mouse
lowest published toxic concentration: 255 ppm/6 hour (10 day male)
|
Reproductive: Effects on embryo or fetus: Fetal death
|
MUREAV 119,377,1983
|
inhalation | mouse
lowest published toxic concentration: 1,200 ppm/90 minute (1 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetal death Reproductive: Specific developmental abnormalities: Homeostasis
MUREAV 176,269,1987
|
inhalation | mouse
lowest published toxic concentration: 1,200 ppm/90 minute (1 day prior to copulation)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetal death Reproductive: Other effects to embryo or fetus
TJADAB 39,563,1989
|
inhalation | mouse
lowest published toxic concentration: 2,700 ppm/6 hour (7 day pregnant)
|
Reproductive: Other effects to embryo or fetus
|
TJADAB 57,231,1998
|
inhalation | mouse
lowest published toxic concentration: 1,800 ppm/1.5 hour (7 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TOSCF2 50,259,1999
|
inhalation | rat
lowest published toxic concentration: 50 ppm/6 hour (91 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
NEZAAQ 45,592,1990
|
inhalation | rat
lowest published toxic concentration: 100 ppm/6 hour (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TXAPA9 48,A84,1979
|
inhalation | rat
lowest published toxic concentration: 100 ppm/6 hour (12 week male/9 week prior to copulation-3 week pregnant)
|
Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
|
TXAPA9 48,A84,1979
|
inhalation | rat
lowest published toxic concentration: 3,600 µg/m3/24 hour (60 day male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct | Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea)
TPKVAL 14,11,1975
|
inhalation | rat
lowest published toxic concentration: 100 ppm/6 hour (12 week prior to copulation-21 day pregnant)
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
TXAPA9 63,382,1982
|
inhalation | rat
lowest published toxic concentration: 150 ppm/7 hour (7-16 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) Reproductive: Specific developmental abnormalities: Musculoskeletal system
NTIS** PB83-258038
|
intraperitoneal | mouse
lowest published toxic dose: 750 mg/kg (25 day male)
|
Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth) | Reproductive: Effects on newborn: Delayed effects
MUREAV 73,133,1980
|
intraperitoneal | mouse
lowest published toxic dose: 150 mg/kg (1 day male)
|
Reproductive: Effects on embryo or fetus: Fetal death
|
MUREAV 73,133,1980
|
intraperitoneal | mouse
lowest published toxic dose: 125 mg/kg (1 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) Reproductive: Specific developmental abnormalities: Eye, ear
TJADAB 53,1,1996
|
intraperitoneal | mouse
lowest published toxic dose: 125 mg/kg (1 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system | Reproductive: Other developmental abnormalities
TJADAB 53,1,1996
|
intravenous | mouse
lowest published toxic dose: 225 mg/kg (10-12 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
TJADAB 19,34A,1979
|
intravenous | mouse
lowest published toxic dose: 450 mg/kg (8-10 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
TJADAB 19,34A,1979
|
intravenous | mouse
lowest published toxic dose: 450 mg/kg (10-12 day pregnant)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
TXAPA9 56,16,1980
|
intravenous | rabbit
lowest published toxic dose: 324 mg/kg (6-14 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
NTIS** PB83-242016
|
intravenous | rabbit
lowest published toxic dose: 81 mg/kg (6-14 day pregnant)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on embryo or fetus: Fetal death
NTIS** #PB83-242016
|
intravenous | rabbit
lowest published toxic dose: 81 mg/kg (6-14 day pregnant)
|
Reproductive: Effects on newborn: Sex ratio
|
NTIS** #PB83-242016
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lowest published toxic dose: 50 ppm/6 hour/2 year
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors
NTPTR* NTP-TR-326,1987
|
inhalation | mouse
lowest published toxic concentration: 3,060 mg/kg/103 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors
NTIS** PB88-169859
|
inhalation | mouse
lowest published toxic concentration: 3,060 mg/kg/102 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Reproductive: Tumorigenic effects: Uterine tumors
NTIS** PB88-169859
|
inhalation | rat
lowest published toxic concentration: 33 ppm/6 hour/2 year- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Brain and Coverings: Tumors Blood: Leukemia
TXAPA9 75,105,1984
|
inhalation | rat
toxic concentration (other than lowest) : 50 ppm/7 hour/2 year- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Blood: Tumors
TXAPA9 76,69,1984
|
inhalation | rat
toxic concentration (other than lowest) : 33 ppm/6 hour/2 year- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Brain and Coverings: Tumors
NRTXDN 6,117,1985
|
inhalation | rat
toxic concentration (other than lowest) : 33 ppm/6 hour/2 year- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Brain and Coverings: Tumors
FCTOD7 24,145,1986
|
oral | rat
lowest published toxic dose: 1,186 mg/kg/2 year- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Gastrointestinal: Tumors Liver: Tumors
BJCAAI 46,924,1982
|
oral | rat
toxic dose : 5,112 mg/kg/2 year- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Gastrointestinal: Tumors Liver: Tumors
BJCAAI 46,924,1982
|
subcutaneous | mouse
lowest published toxic dose: 292 mg/kg/95 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Blood: Lymphoma including Hodgkin's disease Tumorigenic: Tumors at site of application
ZHPMAT 174,383,1981
|
subcutaneous | mouse
toxic dose : 1,090 mg/kg/91 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Blood: Lymphoma including Hodgkin's disease Tumorigenic: Tumors at site of application
BJCAAI 39,588,1979
|
subcutaneous | mouse
toxic dose : 908 mg/kg/95 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Blood: Lymphoma including Hodgkin's disease Tumorigenic: Tumors at site of application
ZHPMAT 174,383,1981
|
subcutaneous | mouse
toxic dose : 2,576 mg/kg/95 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Blood: Lymphoma including Hodgkin's disease Tumorigenic: Tumors at site of application
ZHPMAT 174,383,1981
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | dog
lethal concentration (50 percent kill): 960 ppm/4 hour
|
Eye: Lacrimation | Gastrointestinal: Nausea or vomiting Gastrointestinal: Hypermotility, diarrhea
AMIHAB 13,237,1956
|
inhalation | guinea pig
lethal concentration (50 percent kill): 1,500 mg/m3/4 hour
|
N/R
|
85GMAT -,67,1982
|
inhalation | human
lowest published toxic concentration: 12,500 ppm/10S
|
Olfaction: Other olfaction effects
|
JOHYAY 32,409,1932
|
inhalation | mouse
lethal concentration (50 percent kill): 836 ppm/4 hour
|
N/R
|
NTIS** PB214-270
|
inhalation | rat
lethal concentration (50 percent kill): 800 ppm/4 hour
|
Lung, Thorax, or Respiration: Other changes | Liver: Other changes Kidney, Ureter, and Bladder: Other changes
34ZIAG -,258,1969
|
inhalation | woman
lowest published toxic concentration: 500 ppm/2 minute
|
Behavioral: Convulsions or effect on seizure threshold | Gastrointestinal: Nausea or vomiting Lung, Thorax, or Respiration: Other changes
DICPBB 15,384,1981
|
intraperitoneal | mouse
lethal dose (50 percent kill): 175 mg/kg
|
N/R
|
GISAAA 48(1),23,1983
|
intravenous | dog
lethal dose (50 percent kill): 330 mg/kg
|
Eye: Other eye effects | Behavioral: Convulsions or effect on seizure threshold Gastrointestinal: Nausea or vomiting
JTCSAQ 61,309,1971
|
intravenous | mouse
lethal dose (50 percent kill): 290 mg/kg
|
N/R
|
APTOA6 43,69,1978
|
intravenous | rabbit
lowest published lethal dose: 175 mg/kg
|
Eye: Other eye effects | Behavioral: Muscle weakness Behavioral: Rigidity (includes catalepsy)
JOHYAY 32,409,1932
|
oral | guinea pig
lethal dose (50 percent kill): 270 mg/kg
|
N/R
|
JIHTAB 23,259,1941
|
oral | rat
lethal dose (50 percent kill): 72 mg/kg
|
N/R
|
SPEADM 78-1,17,1978
|
subcutaneous | cat
lowest published lethal dose: 100 mg/kg
|
N/R
|
HDWU** -,-,1933
|
subcutaneous | rat
lethal dose (50 percent kill): 187 mg/kg
|
N/R
|
GISAAA 48(1),23,1983
|
unreported route | rat
lowest published lethal dose: 200 mg/kg
|
Lung, Thorax, or Respiration: Other changes | Liver: Other changes Kidney, Ureter, and Bladder: Other changes
34ZIAG -,258,1969
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | dog
lowest published toxic concentration: 290 ppm/6 hour/6 week- intermittent
|
Blood: Pigmented or nucleated red blood cells | Blood: Changes in erythrocyte (RBC) count
AMIHAB 13,237,1956
|
inhalation | dog
lowest published toxic concentration: 102 ppm/26 week- intermittent
|
Blood: Pigmented or nucleated red blood cells | Blood: Changes in erythrocyte (RBC) count
AMIHAB 13,237,1956
|
inhalation | monkey
lowest published toxic concentration: 100 ppm/7 hour/2 year- intermittent
|
Eye: Other eye effects
|
TOXID9 12,354,1992
|
inhalation | mouse
lowest published toxic concentration: 800 ppm/6 hour/14 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
NTPTR* NTP-TR-326,1987
|
inhalation | mouse
lowest published toxic concentration: 400 ppm/6 hour/13 week- intermittent
|
Kidney, Ureter, and Bladder: Changes in bladder weight | Blood: Normocytic anemia Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
JOUOD4 14,33,1992
|
inhalation | mouse
lowest published toxic concentration: 600 ppm/6 hour/14 week- intermittent
|
Olfaction: Other olfaction effects | Endocrine: Other changes Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
NTPTR* NTP-TR-326,1987
|
inhalation | mouse
lowest published toxic concentration: 450 mg/m3/6 hour/10 week- intermittent
|
Liver: Changes in liver weight | Endocrine: Changes in spleen weight Related to Chronic Data: Changes in testicular weight
NTIS** OTS0534608
|
inhalation | rat
lowest published toxic concentration: 406 ppm/6 hour/6 week- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
AMIHAB 13,237,1956
|
inhalation | rat
lowest published toxic concentration: 300 µg/m3/24 hour/83 day- continuous
|
Behavioral: Muscle contraction or spasticity | Blood: Other changes Nutritional and Gross Metabolic: Changes in: Cl
GISAAA 31(10),3,1966
|
inhalation | rat
lowest published toxic concentration: 500 ppm/6 hour/13 week- intermittent
|
Behavioral: Food intake (animal) | Liver: Other changes
NEZAAQ 43,1053,1988
|
intravenous | rabbit
lowest published toxic dose: 81 mg/kg/9 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
NTIS** #PB83-242016
|
intravenous | rabbit
lowest published toxic dose: 72 mg/kg/4 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
NTIS** #PB83-242016
|
intravenous | rabbit
lowest published toxic dose: 144 mg/kg/4 day- intermittent
|
Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
|
NTIS** #PB83-242016
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 1 ppm
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Suspected Human Carcinogen
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 36,189,1985
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Limited Evidence
|
IMSUDL 7,205,1987
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Limited Evidence
|
IMEMDT 60,73,1994
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 60,73,1994
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 1
|
IMEMDT 60,73,1994
|
TOXICOLOGY REVIEW
|
|
JJOMDZ 15,808,1973
|
TOXICOLOGY REVIEW
|
|
CMTVAS 10(3),49,1973
|
TOXICOLOGY REVIEW
|
|
AEHLAU 8,700,1964
|
TOXICOLOGY REVIEW
|
|
CRTXB2 30,595,2000
|
TOXICOLOGY REVIEW
|
|
TOLED5 138,1,2003
|
TOXICOLOGY REVIEW
|
|
MUREAV 543,201,2003
|
TOXICOLOGY REVIEW
|
|
MUREAV 5432012003
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,227,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,109,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,151,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 580,91,2005
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,347,2004
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988
|
PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION
|
FEREAC 54,7740,1989
|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF
|
PESTICIDES: Supported
|
RBREV* -,182,1998
|
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 50 ppm (90 mg/m3)
|
DTLVS* 3,112,1971
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
see Code of Federal Regulations (CFR) 29,1926.1147
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 50 ppm (90 mg/m3)
|
CFRGBR 41,50-204.50,1994
|
Occupational Safety and Health Administration (OSHA)
|
cancer hazard
|
CFRGBR 29,1910.1047,1987
|
Occupational Exposure Limit - ARAB Republic of Egypt
|
time-weighted average 10 ppm (20 mg/m3), JAN1993
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 1 ppm (2 mg/m3), Carcinogen, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 1 ppm (1.8 mg/m3), Carcinogen, JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 1 ppm (1.8 mg/m3), JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 1 ppm (2.8 mg/m3), Carcinogen, JAN1999
|
Occupational Exposure Limit - GERMANY
|
Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - HUNGARY
|
short term exposure limit 1 mg/m3, Carcinogen, JAN1993
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 0.84 mg/m3, 2003
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 1 ppm, JAN1999
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 1 mg/m3, MAC(short term exposure limit) 3 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
time-weighted average 50 ppm, short term exposure limit 1 mg/m3, JAN1993
|
Occupational Exposure Limit - SWEDEN
|
NGV 1 ppm (2 mg/m3), KTV 5 ppm (9 mg/m3), Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 1 ppm (2 mg/m3), Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - TURKEY
|
time-weighted average 50 ppm (90 mg/m3), JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 5 ppm (9.2 mg/m3), Carcinogen, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Suspected Human Carcinogen
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Suspected Human Carcinogen |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO ETHYLENE OXIDE-air
|
Carcinogen; | 8 hour time-weighted average 0.1 ppm; ceiling concentration 5 ppm/10 minute
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 32550; | Number of Industries 67; Total Number of Facilities 7,411; Number of Occupations 74; Total Number of Employees Exposed 107,450
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 32550; |
Number of Industries 89; Total Number of Facilities 10,657; Number of Occupations 104; Total Number of Employees Exposed 270,683; Total Number of Female Employees Exposed 120,086 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
ATSDR TOXICOLOGY PROFILE (NTIS** PB/91/180554/AS)
|
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat
|
EPA GENETOX PROGRAM 1988, Positive: D melanogaster-reciprocal translocation
|
EPA GENETOX PROGRAM 1988, Positive: Rodent dominant lethal; Rodent heritable translocation
|
EPA GENETOX PROGRAM 1988, Positive: Mammalian micronucleus; N crassa-reversion
|
EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test
|
EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal; UDS in mouse germ cells
|
EPA GENETOX PROGRAM 1988, Negative: Mouse specific locus
|
EPA GENETOX PROGRAM 1988, Positive: CHO gene mutation
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE
|
FEREAC 47,26992,82
|
Used in the production of glycols, nontonic surface-active agents and ethanolamines
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9104
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH CURRENT INTELLIGENCE BULLETIN 35, MAY 1981
|
NIOSH CURRENT INTELLIGENCE BULLETIN 52, JULY 1989
|
NIOSH Analytical Method, 1994: Ethylene oxide, 1614 or by portable GC, 3702
|
NCI Carcinogenesis Studies (inhal);clear evidence:mouse
|
NTP 11th Report on Carcinogens,2004:Known to be human carcinogen
|
OSHA ANALYTICAL METHOD #30, SUPERSEDED BY #50
|
PASSIVE MONITOR, OSHA ANALYTICAL METHOD #49
|
|
REFERENCES:
CODEN
|
|
REFERENCE
34ZIAG
|
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969
|
47YKAF
|
"Sporulation and Germination, Proceedings of the Eighth International Spore Conference, 1980,"
Washington, DC, American Soc. of Microbiology, 1981
|
85GMAT
|
"Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F.,
et al., Moscow, Centre of International Projects, GKNT, 1982
|
AEHLAU
|
Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC
20016) V.1- 1960-
|
AMIHAB
|
AMA Archives of Industrial Health. (Chicago, IL) V.11-21, 1955-60. For publisher
information, see AEHLAU.
|
AMIHBC
|
AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54.
For publisher information, see AEHLAU.
|
APTOA6
|
Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher
information, see PHTOEH
|
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
ATAREK
|
AAMI Technology Assessment Report. (Assoc. for the Advancement of Medical Instrumentation,
1901 N. Ft. Myer Dr., Suite 602, Arlington, VA 22209) No.1-81- 1981-
|
BJCAAI
|
British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS,
UK) V.1- 1947-
|
BUYRAI
|
Bulletin of Parenteral Drug Association. (Philadelphia, PA) V.1-31, 1946-77.
|
CBINA8
|
Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1969-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CMTVAS
|
Cahiers de Medecine du Travail. (Association Professionnelle Belge des Medecine du Travail,
rue du Bultia, 6280 Gerpinnes, Belgium) V.1- 1963-
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
CRTXB2
|
CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton,
FL 33431) V.1- 1971-
|
DICPBB
|
Drug Intelligence and Clinical Pharmacy. (POB 42435, Cincinnati, OH 45242) V.3- 1969-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ENMUDM
|
Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see
EMMUEG.
|
ESKHA5
|
Eisei Shikenjo Hokoku. Bulletin of the Institute of Hygienic Sciences. (Kokuritsu Eisei
Shikenjo Kagaku, 18-1 Bushitsu Johobu, Setagaya-ku, Tokyo 158, Japan) V.1- 1886-
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
FCTXAV
|
Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see
FCTOD7.
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
HDWU**
|
"Beitrage zur Toxikologie des Athylenoxyds und der Glykole, Dissertation," Hofbauer, A.,
Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1933
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
IMSUDL
|
IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY
12210) No.1- 1979-
|
JIHTAB
|
Journal of Industrial Hygiene and Toxicology. (Cambridge, MA) V.18-31, 1936-49. For
publisher information, see AEHLAU.
|
JJOMDZ
|
JOM, Journal of Occupational Medicine. (American Occupational Medicine Assoc., 150 N. Wacker
Dr., Chicago, IL 60606) V.10- 1968-
|
JOHYAY
|
Journal of Hygiene. (Cambridge Univ. Press, 32 E. 57th St., New York, NY 10022) V.1- 1901-
|
JOUOD4
|
Journal of UOEH (University of Occupational and Environmental Health). (Univ. of Occupational
and Environmental Health, 1-1 Iseigaoka, Yahata-nishi-ku, Kitakyushu 807, Japan) V.1- 1979-
|
JTCSAQ
|
Journal of Thoracic and Cardiovascular Surgery. (C.V. Mosby Co., 11830 Westline Industrial
Dr., St. Louis, MO 63141) V.38- 1959-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
MGGEAE
|
Molecular and General Genetics. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed.
Rep. Ger.) V.99- 1967-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
MUTAEX
|
Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ,
UK) V.1- 1986-
|
NEZAAQ
|
Nippon Eiseigaku Zasshi. Japanese Journal of Hygiene. (Nippon Eisei Gakkai, c/o Kyoto
Daigaku Igakubu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.1- 1946-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NRTXDN
|
Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979-
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
NTPTR*
|
National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709)
No.206-
|
PAACA3
|
Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston
St., Baltimore, MD 21202) V.1- 1954-
|
PHMGBN
|
Pharmacology: International Journal of Experimental and Clinical Pharmacology. (S. Karger AG,
Postfach CH-4009 Basel, Switzerland) V.1- 1968-
|
RBREV*
|
Status of Pesticides in Registration, Reregistration, and Special Review (Rainbow Report),
Special Review and Reregistration Division Office of Pesticide Programs U.S. Environmental
Protection Agency, 401 M. Street, S.W., Washington, D.C. 20460, Spring 1998
|
SPEADM
|
Special Publication of the Entomological Society of America. (4603 Calvert Rd., College Park,
MD 20740)
|
SWEHDO
|
Scandinavian Journal of Work, Environment and Health. (Haartmaninkatu 1, SF-00290 Helsinki,
29, Finland) V.1- 1975-
|
TCMUD8
|
Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New
York, NY 10003) V.1- 1980-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TNICS*
|
Toxicology of New Industrial Chemical Substances. English translation of TPKVAL. (USSR
Academy of Medical Sciences, Meditsina, Moscow, USSR)
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TPKVAL
|
Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial
Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow,
USSR) No.1- 1961-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
ZEVBA5
|
Zeitschrift fuer Vererbungslehre. (Berlin, Fed. Rep. Ger.) V.89-98, 1958-66. For publisher
information, see MGGEAE.
|
ZHPMAT
|
Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung
1: Originale, Reihe B: Hygiene, Krankenhaushygiene, Betriebshygiene, Praeventive Medizin.
(Stuttgart, Fed. Rep. Ger.) V.155-169, 1971-1979. For publisher information, see ZAOMDC.
|
|